Huons Group's Humedix accelerates international expansion with premium hyaluronic acid filler Elravie Premier.
Humedix recently announced that Elravie Premier hyaluronic acid filler has received a product license from the Russian Federal Service for Health Services Supervision (Roszdravnadzor).
Five products have been approved in Russia: Elravie Premier Light-L, Elravie Premier DeepLine-L, Elravie Premier UltraVolume Line-L (1mL/2mL) and Elravie Balance.
Elavier Premier is a domestic filler brand born from Humedix's original technology for producing high-purity fixative hyaluronic acid. It is stable by applying the Hi-B (High Viscoelasticity-Hybrid) method and maintains the unique viscosity of hyaluronic acid by increasing cross-linking efficiency. In recognition of its quality and safety, the product has been approved in Russia following CE certification in Korea, CE certification in Europe, and NMPA certification in China.
Starting with the Russian approval, Humedix plans to promote the quality and stability of hyaluronic acid fillers to the global market and expand its influence.
"We are pleased to announce the approval of Elavier Premier Hyaluronic Acid Filler in Russia, which will allow us to introduce the product's excellent quality and technology to the global market," said a representative from Humedix. "We will continue to strive to further expand our influence in overseas markets."
Check this product with KoreaBeautyTech here: https://www.koreabeautytech.com/en-in/products/elravie-light-l-deep-line-l-volumizing-volume-l?_pos=1&_sid=2ce4c4fa4&_ss=r
